Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through The Week Ended October 14, 2022.
Week ending 10/14/2022:
Biotech: 5 transactions (3 Follow-Ons, 1 PIPE and 1 RD) totaling just over $600 Million
Med Tech: No Current Week Financings
2022:
121 Biotech transactions totaling just under $15 Billion v. 2021 YTD: 267 Biotech transactions totaling just over $35 Billion
40 Biotech transactions totaling just under $4 Billion in Q2 2022 v. Q2 2021: 64 Biotech transactions totaling just over $10 Billion
10 Med Tech transactions totaling just over $800 Million v. 2021 YTD: 63 Med Tech transactions totaling just under $10 Billion
No Med Tech transactions in Q2 2022 v. Q2 2021: 13 Med Tech transactions totaling just over $1 Billion
Private Transactions:
Biotech: 222 US Transactions / 54 European Transaction
Med Tech: 136 US Transactions / 21 European Transactions
You're either a big fish (revenue/earnings generating co) or a little fish waiting to be gobbled up. Some little fish are yummy (good data/prospects) some are nasty (poor data/prospects). Discerning, which is which takes a team of scientists, like Lifesci